National Institute of Allergy and Infectious Diseases
NIAID Home Health & Science Research Funding Research News & Events Labs at NIAID About NIAID

About NIAID
 Who We Are and What We Do
 Organization
  Office of the Director
  DAIDS
  DAIT
  DCR
  DEA
  DIR
  DMID
  VRC
 About the Director
 Working at NIAID
 Finding People
 Visitor Information


Division of Acquired Immunodeficiency Syndrome (DAIDS)

HIV/AIDS Network Clinical Trials Units (CTU) and Clinical Research Sites (CRS) 

As of December 1, 2008

NIAID has funded the following Clinical Trials Units (CTU) and their associated Clinical Research Sites (CRS) to implement the clinical research plans of one or more of the six NIAID-funded HIV/AIDS Clinical Trials Networks (see listing to the right).

The HIV/AIDS Clinical Trials Networks and their CTU/CRS will pursue clinical trials to address the highest priorities in HIV/AIDS research, including: (1) vaccine research and development; (2) translational research/drug development; (3) optimization of clinical management, including co-morbidities; (4) microbicides; (5) prevention of mother-to-child transmission of HIV; and (6) prevention of HIV infection.

Clinical Trials Units and Clinical Research Sites Listing (as of December 1, 2008):

back to top

 

NIAID-sponsored HIV/AIDS Clinical Trial Networks

AIDS Clinical Trials Group (ACTG)

HIV Vaccine Trials Network (HVTN)

HIV Prevention Trials Network (HPTN)

International Maternal Pediatric Adolescent AIDS Clinical Trials (IMPAACT)

Microbicide Trials Network (MTN)

International Network for Strategic Initiatives in Global HIV Trials (INSIGHT)

All NIAID-sponsored HIV/AIDS Clinical Trials Networks


Highlights

Dr. Carl Dieffenbach Appointed Director of the NIAID Division of AIDS
Feb. 1, 2008

News Releases

Scientists Learn Why Even Treated Genital Herpes Sores Boost the Risk of HIV Infection
Aug. 3, 2009

Bulletin: Study Suggests Immune Systems of Untreated HIV-Infected Individuals May Deteriorate Faster than Previously Thought
July 29, 2009

Bulletin: NIAID Invites Applications to Conduct Basic Research on HIV Persistence
June 16, 2009

Media Availability: New Strategy Proposed for Designing Antibody-Based HIV Vaccine
June 14, 2009

Special Announcements

  • Status of NIAID Adenovirus-based Vaccine Studies
  • Considerations for HIV Vaccine Clinical Trials in Adolescents
  • Guidance regarding HIV anti-retroviral treatment in developing countries
  • See Also

    HIV/AIDS


     

    NIAID-sponsored HIV/AIDS Clinical Trial Networks

    AIDS Clinical Trials Group (ACTG)

    HIV Vaccine Trials Network (HVTN)

    HIV Prevention Trials Network (HPTN)

    International Maternal Pediatric Adolescent AIDS Clinical Trials (IMPAACT)

    Microbicide Trials Network (MTN)

    International Network for Strategic Initiatives in Global HIV Trials (INSIGHT)

    All NIAID-sponsored HIV/AIDS Clinical Trials Networks


    Highlights

    Dr. Carl Dieffenbach Appointed Director of the NIAID Division of AIDS
    Feb. 1, 2008

    News Releases

    Scientists Learn Why Even Treated Genital Herpes Sores Boost the Risk of HIV Infection
    Aug. 3, 2009

    Bulletin: Study Suggests Immune Systems of Untreated HIV-Infected Individuals May Deteriorate Faster than Previously Thought
    July 29, 2009

    Bulletin: NIAID Invites Applications to Conduct Basic Research on HIV Persistence
    June 16, 2009

    Media Availability: New Strategy Proposed for Designing Antibody-Based HIV Vaccine
    June 14, 2009

    Special Announcements

  • Status of NIAID Adenovirus-based Vaccine Studies
  • Considerations for HIV Vaccine Clinical Trials in Adolescents
  • Guidance regarding HIV anti-retroviral treatment in developing countries
  • See Also

    HIV/AIDS